Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.

@article{Tilles2013ManagementOH,
  title={Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.},
  author={Stephen A. Tilles and Larry Borish and Joshua P Cohen},
  journal={Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology},
  year={2013},
  volume={110 2},
  pages={70-4}
}
Hereditary angioedema (HAE) is an autosomal dominant disease characterized by recurrent episodes of edema involving the skin, gastrointestinal tract, and/or airway. With a prevalence of approximately 1 in 50,000, HAE is rare, affecting fewer than 10,000 people in the United States.1 There is a range of severity and frequency of symptoms in patients with HAE. Some patients experience relatively mild symptoms on rare occasions, others have symptoms 1 or more times eachmonth, and still others have… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS